304 filings
Page 14 of 16
6-K
o08 m5mjtf
26 Nov 13
Current report (foreign)
12:00am
20-F
vdkc6s
25 Nov 13
Annual report (foreign)
12:00am
6-K
2niz b2icj161
19 Nov 13
GW Pharmaceuticals plc Reports 2013 Q4 and Full Year Financial Results
12:00am
6-K
fdkm3ofy3404r
15 Nov 13
Current report (foreign)
12:00am
6-K
7tcgxrsy4h 0cipi
12 Nov 13
Current report (foreign)
12:00am
6-K
l93lqw2y o40
21 Oct 13
GW Pharmaceuticals Announces Successful Closing of Mutual Recognition Procedure for Sativex® in France
12:00am
6-K
hfw y10npm
2 Oct 13
GW Pharmaceuticals Announces New Sativex® Data at ECTRIMS
12:00am
6-K
mlyfkjyxp k6k584au
24 Sep 13
Current report (foreign)
12:00am
6-K
efyl6 sr3l54y
23 Sep 13
GW Pharmaceuticals Announces Agreement on Sativex® Pricing in Germany
12:00am
6-K
xpu7rk5q9d177ya2y
18 Sep 13
Current report (foreign)
12:00am
6-K
75a3y
5 Aug 13
GW Pharmaceuticals plc Reports 2013 Third Quarter Financial Results
12:00am
6-K
mrwuuibmme6p7y cw
10 Jun 13
Current report (foreign)
12:00am
6-K
duxb6vg
3 Jun 13
GW Pharmaceuticals plc Reports 2013 Second Quarter Financial Results
12:00am
6-K
3ktsyy935g7x9m4n9m3
31 May 13
GW Pharmaceuticals Announces Exercise of Over-Allotment Option
12:00am
6-K
t81ud096u3b
17 May 13
GW Pharmaceuticals to Report Interim 2013 Results and Host Conference Call on 3 June, 2013
12:00am
EFFECT
u2i78wsurpufndv7293f
7 May 13
Notice of effectiveness
12:00am
424B4
gk97h434uenk uu
2 May 13
Prospectus supplement with pricing info
12:00am
CT ORDER
0171d4e2zo 2y
1 May 13
Confidential treatment order
12:00am
FWP
eftfucx93ypsyob 80e
1 May 13
Free writing prospectus
12:00am
EFFECT
kwpvn
1 May 13
Notice of effectiveness
12:00am